Amarin Corp Ads (AMRN) |
|
6.99 -0.06 (-0.85%)
|
08-07 14:46 |
|
Open: |
7 |
Pre. Close: |
7.05 |
|
High:
|
7.37 |
Low:
|
6.95 |
|
Volume:
|
6,043,375 |
Market Cap:
|
2,695M |
|
|
|
|
Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.185 - 7.219 |
7.219 - 7.251 |
|
Low:
|
6.745 - 6.783 |
6.783 - 6.819 |
|
Close:
|
6.986 - 7.047 |
7.047 - 7.104 |
|
Technical analysis |
as of: 2020-08-07 2:23:55 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 8.61 One year: 10.05 |
| Support: |
Support1: 6.71 Support2: 6.30 |
| Resistance: |
Resistance1: 7.37 Resistance2: 8.61 |
| Pivot: |
6.69  |
| Moving Average: |
MA(5): 6.94 MA(20): 6.69
MA(100): 7.27 MA(250): 13.60 |
| MACD: |
MACD(12,26): 0.02 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 62.89 %D(3): 62.80 |
| RSI: |
RSI(14): 56.31 |
| 52-week: |
High: 26.12 Low: 3.95 Change(%): -49.5 |
| Average Vol(K): |
3-Month: 636206 10-Days: 623974 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AMRN has closed below upper band by 11.5%. Bollinger Bands are 75.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 05 Aug 2020
Amarin: Improving HCP Access Should Drive More Vascepa Sales, Says Analyst - Nasdaq
Tue, 16 Jun 2020
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc. - GlobeNewswire
Tue, 09 Jun 2020
Why Amarin (AMRN) Stock Might be a Great Pick - Yahoo Finance
Tue, 05 May 2020
Amarin (AMRN) Stock Could Stage a Rebound to $15, Says Analyst - Yahoo Finance
Wed, 29 Apr 2020
Is a Beat in Store for Amarin (AMRN) This Earnings Season? - Yahoo Finance
Mon, 06 Apr 2020
Amarin (AMRN) Will Make Excellent Takeover Target, Says Analyst - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
385 |
| Shares Float (M) |
347 |
|
% Held by Insiders
|
0.99 |
|
% Held by Institutions
|
43.74 |
|
Shares Short (K)
|
32,310 |
|
Shares Short P. Month (K)
|
34,120 |
Stock Financials |
|
EPS
|
-0.060 |
|
EPS Est This Year
|
-0.210 |
|
EPS Est Next Year
|
-0.060 |
|
Book Value (p.s.)
|
1.560 |
|
Profit Margin
|
-3.67 |
|
Operating Margin
|
-5.00 |
|
Return on Assets (ttm)
|
-2.5 |
|
Return on Equity (ttm)
|
-5.2 |
|
Qtrly Rev. Growth
|
111.5 |
|
Gross Profit (p.s.)
|
0.866 |
|
Sales Per Share
|
1.327 |
|
EBITDA (p.s.)
|
-0.063 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
33 |
|
Levered Free Cash Flow (M)
|
35 |
Stock Valuations |
|
PE Ratio
|
-116.81 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.49 |
|
Price to Sales
|
5.28 |
|
Price to Cash Flow
|
82.22 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
